PTCH1 and basal cell carcinoma: Its constitutive activity is suppressed by the 12-transmembrane (12TM) protein PTCH1 [60,70,71] and numerous small molecule antagonists including the approved antineoplastic (basal cell carcinoma) drug Vismodegib [72,73].